National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 453102

Case Details

VAERS ID: 453102 (history)  
Age: 15.0  
Gender: Female  
Location: Foreign  
Vaccinated:2010-12-22
Onset:0000-00-00
Submitted: 2012-04-05
Entered: 2012-04-06
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Activities of daily living impaired, Arthralgia, Back pain, Blood count, Blood culture negative, Blood immunoglobulin A normal, Blood immunoglobulin G normal, Blood immunoglobulin M normal, C-reactive protein increased, Complement factor C3, Complement factor C4, DNA antibody negative, Differential white blood cell count, Finger deformity, Joint ankylosis, Laboratory test normal, Musculoskeletal stiffness, Myalgia, Pain in extremity, Red blood cell sedimentation rate, Viral test negative
SMQs:, Rhabdomyolysis/myopathy (broad), Retroperitoneal fibrosis (broad), Dementia (broad), Dystonia (broad), Parkinson-like events (broad), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Eosinophilic pneumonia (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: DNA Ab immunoprecipitation, negative; Serum C-reactive protein, 2; Blood culture, normal: Blood count and differential white count; Serum immunoglobulin A test, normal; Component C3 test, normal; Clinical serology test, virus serology test negative; Component C4 test, normal; Serum immunoglobulin M test, normal; Serum immunological G test, normal; Erythrocyte sedimentation rate, 5/17
CDC Split Type: WAES1105USA04184

Write-up: Information has been received from a consumer on 10-MAY-2011 and not medically confirmed. A Female patient (age unknown) had received the second dose of GARDASIL (lot and batch number not reported) on unspecified date. On an unspecified onset of time she experienced significant joints pain. At the time of reporting the patient had still not recovered. Additional information received from a pediatrician on 28-MAY-2011. Case medically confirmed. The patient was 15 year old and had no relevant medical history. She had received the first dose of GARDASIL (lot and batch number not reported) on 22-DEC-2010 together with a dose of MENINGITEC (other manufacturer), and the second dose of GARDASIL (lot and batch number not reported) on 23-FEB-2011. Eight days after the second dose, she complained from violent pain in hands and feet, which awoke her in the morning and disturbed her in her daily activities and went increasing during the weeks. She was seen by the reporter on 26-MAR-2011 for arthralgia, sensation of ankylosis, but without morning stiffness. The examination showed joints which were not edematous, nor swollen but it showed a deformation of fingers in lateral valgue. Those pain spread to the wrists. There was no fever. A work-up was performed and was normal: Blood count and differential white count, sedimentation rate: 5/17, C-reactive protein (CRP): 2. Latex, Waler Rose, anti-DNA antibodies were negative; Immunoglobulins G, A, M were normal, C3 and C4 normal. As those pain persisted, spread to toes and were invalidating regards to school, the patient went to see a rheumatologist, who confirmed the absence of systemic disease or rheumatological disease. Viral serologies were negative. At the time of reporting, the pains had been persisting for two months and were not decreasing. The patient needed APRANAX 2 to 3 times a day. Follow up received on 26-OCT-2011. Fifteen days after the second dose (and not 8 as previously reported), the patient experienced migratory arthralgia from fingers to wrists and to ankles. She had morning stiffness. The pain was increased on efforts. She also complained from lumbar pain. The inflammatory work-up was normal. She was seen by a rheumatologist. The physical examination was normal. An appointment with an internal medicine physician was scheduled. The patient was seen for her lumbar pain. The physical examination showed sensitivity on 3 vertebras. The patient was due to be seen again. At the time of reporting, the patient had not recovered. Follow-up information received on 28-MAR-2012: case upgraded to serious upon the basis on the following information: The patient had no swelling, no redness and no inflammation. She observed having fingers deformity. She had difficulties writing in her daily life and need school assistance. Furthermore, she could not longer practice sport. An individual plan had been put into place at school. The patient was suffering since several months and experienced pain in whole body of myalgia type. No diagnosis had been made. The physician agreed to consider this case as serious due to the patient''s daily life difficulties leading to disability. Other business partner numbers include E2011-02891. No further information is available.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=453102


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166